SCHEMBL31204368

SCHEMBL31204368

O=C1OC(Br)c2cc(Br)cc(F)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11403388 0.81 CA1 (0.34) —
SCHEMBL26122062 0.79 NMT1 (0.32) —
SCHEMBL25151104 0.79 MAOA (0.35) —
SCHEMBL26124281 0.78 KDM1A (0.33) —
SCHEMBL25309741 0.74 HTR2C (0.36) —
SCHEMBL86917 0.67 S100A4 (0.42) —
SCHEMBL11399386 0.66 HTR2A (0.36) —
SCHEMBL30451169 0.64 TSHR (0.38) —
SCHEMBL26183091 0.64 TSHR (0.38) —
SCHEMBL17075818 0.63 CYP1A2 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724436-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2026-04-15 — — EP disclosed
WO-2024259017-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2024-12-19 — — WO disclosed
Send feedback